# Berberine Treat Metabolic Syndrome in Schizophrenia

> **NCT03251716** · NA · COMPLETED · sponsor: **Tianjin Anding Hospital** · enrollment: 36 (actual)

## Conditions studied

- Metabolic Syndrome
- Female
- Schizophrenia

## Interventions

- **DRUG:** berberine

## Key facts

- **NCT ID:** NCT03251716
- **Lead sponsor:** Tianjin Anding Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-01
- **Primary completion:** 2017-10-30
- **Final completion:** 2017-12-30
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2018-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03251716

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03251716, "Berberine Treat Metabolic Syndrome in Schizophrenia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03251716. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*